Per the program's published design paper (Giblin et al., Diabetes, Obesity and Metabolism , 2026), the core registrational program consists of four trials : TRIUMPH-1 (NCT05929066): 80-week weight management basket trial, adults with obesity/overweight without diabetes (N=2,339), with knee osteoarthritis and obstructive sleep apnea substudies nested inside it
Who may benefit from combined HRT and GLP-1 treatment Not everyone wants or benefits from both treatments, but certain situations may make the combination worth exploring with a clinician: People in perimenopause or menopause experiencing stubborn weight changes despite consistent efforts Those already on HRT who want additional support for weight management People experiencing weight changes alongside metabolic concerns to discuss with a clinician Those who haven't responded well to GLP-1 alone and have hormonal factors at play What works for one person may not be appropriate for another
Why Gradual Dose Increases Are Important Slowly increasing the dose is important for getting good results with fewer side effects when you use semaglutide
Your chances of getting a false positive due to a chemical pregnancy go up if you test before your period date (4)
However, the difference in weight loss outcomes between sites is typically modestthe dose strength and your personal metabolic response matter far more than whether you choose your abdomen or thigh
The distance between the eyes, nose, and mouth appears balanced and compact, creating: A younger appearance Better facial harmony Softer facial impressions Enhanced photogenic qualities This proportion often gives the illusion of a naturally youthful face without looking artificially altered